Pediatric Interventional Cardiology Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis
Description
Pediatric Interventional Cardiology Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis
Global Pediatric Interventional Cardiology Market is estimated to reach US$ 2,190.1 Million by 2027. Pediatric interventional cardiology is a sub-specialty of cardiology that focuses on using particular catheter-based procedures to treat cardiac problems in newborns, children, and adolescents up to the age of 18. Balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis are some of the procedures available. In addition, as compared to traditional cardiology procedures, pediatric interventional cardiology is less invasive, resulting in fewer post-surgery problems. Hence, they are widely utilized to perform angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect corrective treatments.
Global Pediatric Interventional Cardiology Industry is anticipated to expand at a CAGR of 6.39% during 2021-2027:
The global Pediatric Interventional Cardiology Market Size is expanding rapidly, owing to a growth in the number of children with cardiac disorders and technical breakthroughs in the area. The worldwide pediatric interventional cardiology devices demand is also being driven by the increased incidence of congenital cardiac diseases and government initiatives in this field. In addition, the worldwide pediatric interventional cardiology devices market is benefiting from rising awareness and popularity of more minor invasive procedures.
Congenital Heart Defect Closure Devices and Transcatheter Heart Valves are significant segments:
By Device Type, the dominance of congenital heart defect closure devices in the pediatric interventional cardiology market is due to an increase in the number of cases of congenital disabilities and increased awareness of the necessity for pediatric interventional cardiology devices. Furthermore, because cardiac procedures involving transcatheter heart valves are more effective, the market for transcatheter heart valves is predicted to develop at a constant rate throughout the forecast period.
The Hospitals Segment Dominates the Market for Global Pediatric Interventional Cardiology Devices:
The hospital segment will lead the Paediatric Interventional Cardiology Devices market in 2021 and beyond. The domination of hospitals can be attributed to well-equipped infrastructure, the availability of technical equipment, an increase in the number of practitioners and patients, and an increase in collaborations to help alleviate the load of diagnosis and treatment around the world.
In addition, the availability of sophisticated technology to monitor pediatric cardiac abnormalities and a change in attention toward ambulatory centers for treatment has increased the number of patients choosing mobile facilities for diagnosis. As a result, there is an association between ambulatory center expansion and ambulatory center growth.
North America Dominates the Global Paediatric Interventional Cardiology Devices Industry:
According to our research, North America dominates the global pediatric interventional cardiology devices market, owing to the rising frequency of cardiac illnesses among children and the region's technical improvement. In the next few years, the pediatric interventional cardiology devices market in Asia-Pacific is predicted to rise rapidly.
In the Asian region, China and India are expected to be the fastest expanding markets for pediatric interventional cardiology devices. This is due to massive investments in these countries by various multinational corporations. Large patient pools, increased government funding, and improved healthcare facilities are the primary driving forces for emerging countries' pediatric interventional cardiology devices market.
Key Players:
The international market for pediatric interventional cardiology is highly consolidated, oligopolistic, and competitive. Furthermore, the market is capital-intensive, necessitating significant investments in R&D initiatives. The global pediatric interventional cardiology market is monopolized by Cardinal Health Inc., Medtronic Inc., Abbott Laboratories, Boston Scientific Corporation, General Electric, Siemens AG, and Koninklijke Philips N.V.
Furthermore, these market participants in the Global Pediatric Interventional Cardiology Industry are focusing on expanding their product portfolios through inorganic growth strategies including acquisitions, mergers, and collaborations.
How COVID-19 Turned Down the Global Paediatric Interventional Cardiology Market:
The COVID-19 pandemic significantly impacted pediatric cardiac care worldwide, resulting in fewer hospitalizations and cardiac operations. Thus, in a resource-constrained setting, such a considerable reduction in the number of procedures had a significant impact. However, the recovery and vaccine data have shown to be valuable in establishing a strategy to manage the COVID-19 pandemic's future effects. Thus, as per our analysis, Global Paediatric Interventional Cardiology Market was US$ 1,510.3 Million in 2021.
Renub Research latest report “Paediatric Interventional Cardiology Market, Global Forecast By Device Type (Congenital Heart Defect Closure Devices and Transcatheter Heart Valves), End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinic), Region (North America, Europe, Asia Pacific and Middle East & Africa), Companies (Cardinal Health Inc., Medtronic Inc., Abbott Laboratories, Boston Scientific Corporation, General Electric, Siemens AG, and Koninklijke Philips N.V)” provides a detailed analysis of Paediatric Interventional Cardiology Industry.
Device Type - Market has been covered from 2 viewpoints:
1. Congenital Heart Defect Closure Devices
2. Transcatheter Heart Valves
End Use - Market has been covered from 3 viewpoints:
1. Hospitals
2. Ambulatory Surgical Centers
3. Specialty Clinic
Region - Market has been covered from 4 viewpoints:
1. North America
2. Europe
3. Asia Pacific
4. Middle East & Africa
Company Insights:
• Overview
• Recent Development & Strategies
• Financial Insights
Companies Covered:
1. Cardinal Health Inc.
2. Medtronic, Inc.
3. Abbott Laboratories
4. Boston Scientific Corporation
5. General Electric
6. Siemens AG
7. Koninklijke Philips N.V
Global Pediatric Interventional Cardiology Market is estimated to reach US$ 2,190.1 Million by 2027. Pediatric interventional cardiology is a sub-specialty of cardiology that focuses on using particular catheter-based procedures to treat cardiac problems in newborns, children, and adolescents up to the age of 18. Balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis are some of the procedures available. In addition, as compared to traditional cardiology procedures, pediatric interventional cardiology is less invasive, resulting in fewer post-surgery problems. Hence, they are widely utilized to perform angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect corrective treatments.
Global Pediatric Interventional Cardiology Industry is anticipated to expand at a CAGR of 6.39% during 2021-2027:
The global Pediatric Interventional Cardiology Market Size is expanding rapidly, owing to a growth in the number of children with cardiac disorders and technical breakthroughs in the area. The worldwide pediatric interventional cardiology devices demand is also being driven by the increased incidence of congenital cardiac diseases and government initiatives in this field. In addition, the worldwide pediatric interventional cardiology devices market is benefiting from rising awareness and popularity of more minor invasive procedures.
Congenital Heart Defect Closure Devices and Transcatheter Heart Valves are significant segments:
By Device Type, the dominance of congenital heart defect closure devices in the pediatric interventional cardiology market is due to an increase in the number of cases of congenital disabilities and increased awareness of the necessity for pediatric interventional cardiology devices. Furthermore, because cardiac procedures involving transcatheter heart valves are more effective, the market for transcatheter heart valves is predicted to develop at a constant rate throughout the forecast period.
The Hospitals Segment Dominates the Market for Global Pediatric Interventional Cardiology Devices:
The hospital segment will lead the Paediatric Interventional Cardiology Devices market in 2021 and beyond. The domination of hospitals can be attributed to well-equipped infrastructure, the availability of technical equipment, an increase in the number of practitioners and patients, and an increase in collaborations to help alleviate the load of diagnosis and treatment around the world.
In addition, the availability of sophisticated technology to monitor pediatric cardiac abnormalities and a change in attention toward ambulatory centers for treatment has increased the number of patients choosing mobile facilities for diagnosis. As a result, there is an association between ambulatory center expansion and ambulatory center growth.
North America Dominates the Global Paediatric Interventional Cardiology Devices Industry:
According to our research, North America dominates the global pediatric interventional cardiology devices market, owing to the rising frequency of cardiac illnesses among children and the region's technical improvement. In the next few years, the pediatric interventional cardiology devices market in Asia-Pacific is predicted to rise rapidly.
In the Asian region, China and India are expected to be the fastest expanding markets for pediatric interventional cardiology devices. This is due to massive investments in these countries by various multinational corporations. Large patient pools, increased government funding, and improved healthcare facilities are the primary driving forces for emerging countries' pediatric interventional cardiology devices market.
Key Players:
The international market for pediatric interventional cardiology is highly consolidated, oligopolistic, and competitive. Furthermore, the market is capital-intensive, necessitating significant investments in R&D initiatives. The global pediatric interventional cardiology market is monopolized by Cardinal Health Inc., Medtronic Inc., Abbott Laboratories, Boston Scientific Corporation, General Electric, Siemens AG, and Koninklijke Philips N.V.
Furthermore, these market participants in the Global Pediatric Interventional Cardiology Industry are focusing on expanding their product portfolios through inorganic growth strategies including acquisitions, mergers, and collaborations.
How COVID-19 Turned Down the Global Paediatric Interventional Cardiology Market:
The COVID-19 pandemic significantly impacted pediatric cardiac care worldwide, resulting in fewer hospitalizations and cardiac operations. Thus, in a resource-constrained setting, such a considerable reduction in the number of procedures had a significant impact. However, the recovery and vaccine data have shown to be valuable in establishing a strategy to manage the COVID-19 pandemic's future effects. Thus, as per our analysis, Global Paediatric Interventional Cardiology Market was US$ 1,510.3 Million in 2021.
Renub Research latest report “Paediatric Interventional Cardiology Market, Global Forecast By Device Type (Congenital Heart Defect Closure Devices and Transcatheter Heart Valves), End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinic), Region (North America, Europe, Asia Pacific and Middle East & Africa), Companies (Cardinal Health Inc., Medtronic Inc., Abbott Laboratories, Boston Scientific Corporation, General Electric, Siemens AG, and Koninklijke Philips N.V)” provides a detailed analysis of Paediatric Interventional Cardiology Industry.
Device Type - Market has been covered from 2 viewpoints:
1. Congenital Heart Defect Closure Devices
2. Transcatheter Heart Valves
End Use - Market has been covered from 3 viewpoints:
1. Hospitals
2. Ambulatory Surgical Centers
3. Specialty Clinic
Region - Market has been covered from 4 viewpoints:
1. North America
2. Europe
3. Asia Pacific
4. Middle East & Africa
Company Insights:
• Overview
• Recent Development & Strategies
• Financial Insights
Companies Covered:
1. Cardinal Health Inc.
2. Medtronic, Inc.
3. Abbott Laboratories
4. Boston Scientific Corporation
5. General Electric
6. Siemens AG
7. Koninklijke Philips N.V
Table of Contents
100 Pages
- 1. Introduction
- 2. Research & Methodology
- 3. Executive Summary
- 4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
- 5. Global Pediatric Interventional Cardiology Market
- 6. Market Share – Global Pediatric Interventional Cardiology Market
- 6.1 By Device Type
- 6.2 By End Use
- 6.3 By Region
- 7. Device Type – Global Pediatric Interventional Cardiology Market
- 7.1 Congenital Heart Defect Closure Devices
- 7.2 Transcatheter Heart Valves
- 8. End Use – Global Pediatric Interventional Cardiology Market
- 8.1 Hospitals
- 8.2 Ambulatory Surgical Centers
- 8.3 Specialty Clinic
- 9. Region – Global Pediatric Interventional Cardiology Market
- 9.1 North America
- 9.2 Europe
- 9.3 Asia Pacific
- 9.4 Middle East & Africa
- 10. Porters Five Forces
- 10.1 Bargaining Power of Buyers
- 10.2 Bargaining Power of Suppliers
- 10.3 Degree of Competition
- 10.4 Threat of New Entrants
- 10.5 Threat of Substitutes
- 11. Company Analysis
- 11.1 Cardinal Health Inc.
- 11.1.1 Overview
- 11.1.2 Recent Development
- 11.1.3 Financial Insights
- 11.2 Medtronic, Inc.
- 11.2.1 Overview
- 11.2.2 Recent Development
- 11.2.3 Financial Insights
- 11.3 Abbott Laboratories
- 11.3.1 Overview
- 11.3.2 Recent Development
- 11.3.3 Financial Insights
- 11.4 Boston Scientific Corporation
- 11.4.1 Overview
- 11.4.2 Recent Development
- 11.4.3 Financial Insights
- 11.5 General Electric
- 11.5.1 Overview
- 11.5.2 Recent Development
- 11.5.3 Financial Insights
- 11.6 Siemens AG
- 11.6.1 Overview
- 11.6.2 Recent Development
- 11.6.3 Financial Insights
- 11.7 Koninklijke Philips N.V
- 11.7.1 Overview
- 11.7.2 Recent Development
- 11.7.3 Financial Insights
- List of Figures:
- Figure-01: Global – Pediatric Interventional Cardiology Market (Million US$), 2016 – 2021
- Figure-02: Global – Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 – 2027
- Figure-03: Device Type – Congenital Heart Defect Closure Devices Market (Million US$), 2016 – 2021
- Figure-04: Device Type – Forecast for Congenital Heart Defect Closure Devices Market (Million US$), 2022 – 2027
- Figure-05: Device Type – Transcatheter Heart Valves Market (Million US$), 2016 – 2021
- Figure-06: Device Type – Forecast for Transcatheter Heart Valves Market (Million US$), 2022 – 2027
- Figure-07: End Use – Hospitals Market (Million US$), 2016 – 2021
- Figure-08: End Use – Forecast for Hospitals Market (Million US$), 2022 – 2027
- Figure-09: End Use – Ambulatory Surgical Centers Market (Million US$), 2016 – 2021
- Figure-10: End Use – Forecast for Ambulatory Surgical Centers Market (Million US$), 2022 – 2027
- Figure-11: End Use – Specialty Clinic Market (Million US$), 2016 – 2021
- Figure-12: End Use – Forecast for Specialty Clinic Market (Million US$), 2022 – 2027
- Figure-13: North America – Pediatric Interventional Cardiology Market (Million US$), 2016 – 2021
- Figure-14: North America – Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 – 2027
- Figure-15: Europe – Pediatric Interventional Cardiology Market (Million US$), 2016 – 2021
- Figure-16: Europe – Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 – 2027
- Figure-17: Asia Pacific – Pediatric Interventional Cardiology Market (Million US$), 2016 – 2021
- Figure-18: Asia Pacific – Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 – 2027
- Figure-19: Middle East & Africa – Pediatric Interventional Cardiology Market (Million US$), 2016 – 2021
- Figure-20: Middle East & Africa – Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 – 2027
- Figure-21: Cardinal Health Inc. – Global Revenue (Million US$), 2016 – 2021
- Figure-22: Cardinal Health Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-23: Medtronic, Inc. – Global Revenue (Million US$), 2016 – 2021
- Figure-24: Medtronic, Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-25: Abbott Laboratories – Global Revenue (Million US$), 2016 – 2021
- Figure-26: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-27: Boston Scientific Corporation – Global Revenue (Million US$), 2016 – 2021
- Figure-28: Boston Scientific Corporation – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-29: General Electric – Global Revenue (Million US$), 2016 – 2021
- Figure-30: General Electric – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-31: Siemens AG – Global Revenue (Million US$), 2016 – 2021
- Figure-32: Siemens AG – Forecast for Global Revenue (Million US$), 2022 – 2027
- Figure-33: Koninklijke Philips N.V – Global Revenue (Million US$), 2016 – 2021
- Figure-34: Koninklijke Philips N.V – Forecast for Global Revenue (Million US$), 2022 – 2027
- List of Tables:
- Table-01: Global – Pediatric Interventional Cardiology Market Share by Device Type (Percent), 2016 – 2021
- Table-02: Global – Forecast for Pediatric Interventional Cardiology Market Share by Device Type (Percent), 2022 – 2027
- Table-03: Global – Pediatric Interventional Cardiology Market Share by End User (Percent), 2016 – 2021
- Table-04: Global – Forecast for Pediatric Interventional Cardiology Market Share by End User (Percent), 2022 – 2027
- Table-05: Global – Pediatric Interventional Cardiology Market Share by Region (Percent), 2016 – 2021
- Table-06: Global – Forecast for Pediatric Interventional Cardiology Market Share by Region (Percent), 2022 – 2027
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.